SlideShare a Scribd company logo
HIV: NEW PUBLIC HEALTH
INTERVENTIONS
Patrick Loose & Heidi Aiem
HIV, STD & Hepatitis Branch
Public Health Services
County of San Diego Health & Human Services Agency
GETTING TO ZERO
NATIONAL HIV/AIDS STRATEGY
The United States will become a
place where new HIV infections are
rare and when they do occur, every
person regardless of age, gender,
race/ethnicity, sexual orientation,
gender identity or socio-economic
circumstance, will have unfettered
access to high quality, life-
extending care, free from stigma
and discrimination.
HIV IN SAN DIEGO COUNTY
Demographic Group
2014- PREVALENCE
AS OF 12/31/14
Race/Ethnicity HIV AIDS
# % # %
White, not Hispanic 6,623 52.1 3,727 49.6
Black, not Hispanic 1,793 14.1 1,142 15.2
Hispanic 3,674 28.9 2,330 31.0
Asian/Pacific Islander 420 3.3 218 2.9
American Indian/Alaska Native 89 0.7 38 0.5
Multi-Race 114 0.9 60 0.8
Total 12,713 100 7,515 100
CASCADE COMPARISON
CASCADE COMPARISON
CASCADE OF CARE
100%
43%
51%
100%
57%
67%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Total living with HIVa Retention in careb Viral suppressionc
Percent
Persons living with HIV, diagnosed as a resident or known to have
moved to San Diego (N=16,898)
Persons living with HIV, recently diagnosed or recently in care in San
Diego (N=12,863)
Total living with HIVa Virally suppressedcHad > 2 lab testsb
aPersons living with HIV, diagnosed as a resident of San Diego or known to have moved to San Diego defined as persons diagnosed with HIV through
12/31/2013 and living through 12/31/2014, regardless of stage of disease. Recently diagnosed or recently in care in San Diego defined as persons
diagnosed with HIV 2009-2013 or diagnosed prior to 2009 and having at least one CD4 or viral load between 2010 and 2014, living through 12/31/2014,
regardless of stage of disease.
bOf the total, persons who had >2 CD4 or viral load tests at least 3 months apart during 2014.
cOf the total, persons wih virologic supression (<200 copies/mL) at most recent test during 2014.
HIV Care Continuum, San Diego County, 2014
36%
43%43%
49%
45% 46%
38%
44%
34%
28%27%* 28%*
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
1 2
Percent
MSM Continuum of HIV Care by Race/ethnicity
San Diego County, FY 2012/2013
Overall Asian/PI Hispanic White American Indian Black
*Statistically lower than the overall percent; p<.05.
aSan Diego data source: FY 12/13 unmet need file. Of those diagnosed with HIV disease, persons who had >=2 CD4 or viral load tests at least 3 months apart during FY
12/13.
bSan Diego data source: Of those diagnosed with HIV disease, persons with virologic suppression (<=200 copies/mL) at most recent test during FY 12/13.
Viral suppressionbRetention in carea
CONTINUUM OF CARE BY
RACE/ETHNICITY
WHY THE OPTIMISM?
LOCAL LIMITATIONS
Program
Focus
Partner
Services
Scope
Surveillance
Data
Restrictions
Staff
Capacity
THREE FUNDAMENTAL
STRATEGIES
Prevent new
infections
Identify & link
everyone with
HIV to
Treatment
Retain
everyone living
with HIV in care
LEG AUTHORITY
LHO AUTHORITY TO USE HIV SURVEILLANCE DATA
FOR PARTNER SERVICES
 California Health and Safety Code (HSC) Section 120175 provides LHOs with broad
authority to proactively investigate cases of disease, to ascertain the infection source, and
take measures as may be necessary to prevent the spread of the disease or occurrence of
additional cases. Thus, LHOs or their designees, who may be STD Control Branch staff or
DIS/partner services staff working on the LHO’s behalf, may use HIV surveillance data to
identify HIV-infected individuals and initiate partner services with them. HIV surveillance
data consists of LHD-acquired/developed data or data shared with the LHO by the state or
another jurisdictional LHO. LHOs and their DIS/partner services staff should ensure that
their activities adhere to CDC security and confidentiality requirements and California HSC
confidentiality protections within both the surveillance and partner services areas before
proceeding with utilizing HIV surveillance data to identify potential clients for partner
services.
LOCAL HEALTH OFFICERS OR THEIR DESIGNEES,
INCLUDING PARTNER SERVICES STAFF, MAY:
 Tell anyone reasonably believed to be a spouse, or sex, or needle-sharing partner of
a person who has tested positive for HIV about their exposure to HIV. The LHO or
their designees may not disclose any identifying information about the person with
HIV or the physician making the report to the LHD. Any person to whom the
disclosure is made must be referred for appropriate care and follow-up. Health and
Safety Code (HSC) Section 121015[d)])
STATE/LOCAL HEALTH DEPARTMENT HIV
SURVEILLANCE STAFF MAY:
 Disclose personally identifying information about HIV-positive reported individuals to
other local and state health department staff without written authorization. HSC
Section 121025(b) specifically authorizes state and local public health agencies to
disclose personally identifying information to CDPH and to other local public health
agencies when the information is necessary for the investigation, control, or
surveillance of disease. This includes partner services. (HSC Section 121015[d)])
PHYSICIANS OR SURGEONS MAY:
 With the written consent of the patient with HIV, provide LHO or the LHD partner
services staff the patient’s contact information for partner services. (HSC Section
121015[a)])
 Without the written consent of the patient with HIV, notify the spouse, or sex, or
needle-sharing partners of the patient if the physician or surgeon: 1) discusses the
test results with the patient; 2) offers the patient appropriate educational and
psychological counseling, including information on the risks of transmitting HIV to
other people and methods of avoiding those risks; 3) attempts to obtain the patient’s
voluntary consent for notification of their contacts; and 4) notifies the patient of their
intent to notify the patient’s contacts prior to any notification. (HSC Section
121015[b)])
HIV & STD REPORTING
STD REPORTING
 STD Surveillance Unit
 619-692-8501
HIV REPORTING
 HIV/AIDS Epidemiology Unit
 619-692-8545
LINKAGE TO PrEP
GC/HIV PARTNER SERVICES
SURVEILLANCE-BASED HIV
PARTNER SERVICES
DATA 2 CARE
 Patrick Loose, Chief, Patrick.Loose@sdcounty.ca.gov
 Heidi Aiem, Clinic Services Coordination, Heidi.Aiem@sdcounty.ca.gov
 www.stdsandiego.org
 HIV, STD & Hepatitis Branch:
http://www.sandiegocounty.gov/hhsa/programs/phs/hiv_std_hepatitis_branch/inde
x.html
 HIV/AIDS Epidemiology Unit:
http://www.sandiegocounty.gov/hhsa/programs/phs/hiv_aids_epidemiology_unit/re
ports_and_statistics.html

More Related Content

What's hot

12.04.20 | COVID-19 Disparities in Black & Latino Communities: Implications f...
12.04.20 | COVID-19 Disparities in Black & Latino Communities: Implications f...12.04.20 | COVID-19 Disparities in Black & Latino Communities: Implications f...
12.04.20 | COVID-19 Disparities in Black & Latino Communities: Implications f...
UC San Diego AntiViral Research Center
 
Evaluating HIV Clinical Care Quality in Massachusetts Sites Supported through...
Evaluating HIV Clinical Care Quality in Massachusetts Sites Supported through...Evaluating HIV Clinical Care Quality in Massachusetts Sites Supported through...
Evaluating HIV Clinical Care Quality in Massachusetts Sites Supported through...
JSI
 
Illustrating HIV/AIDS in Southeast U.S.
Illustrating HIV/AIDS in Southeast U.S.Illustrating HIV/AIDS in Southeast U.S.
Illustrating HIV/AIDS in Southeast U.S.
AIDSVu
 
Integrating HIV Prevention with Hepatitis C Co‐Infection Programs
Integrating HIV Prevention with Hepatitis C Co‐Infection ProgramsIntegrating HIV Prevention with Hepatitis C Co‐Infection Programs
Integrating HIV Prevention with Hepatitis C Co‐Infection Programs
CDC NPIN
 
San Diego Primary Care Providers' Attitudes to HIV and HIV Testing
San Diego Primary Care Providers' Attitudes to HIV and HIV TestingSan Diego Primary Care Providers' Attitudes to HIV and HIV Testing
San Diego Primary Care Providers' Attitudes to HIV and HIV Testing
UC San Diego AntiViral Research Center
 
Do 1 Thing - Dr. Stacey Trooskin
Do 1 Thing - Dr. Stacey TrooskinDo 1 Thing - Dr. Stacey Trooskin
Do 1 Thing - Dr. Stacey Trooskin
Office of HIV Planning
 
2017 Ottawa County Department of Public Health Annual Report
2017 Ottawa County Department of Public Health Annual Report2017 Ottawa County Department of Public Health Annual Report
2017 Ottawa County Department of Public Health Annual Report
Ottawa County Department of Public Health
 
Veterans and Health Insurance
Veterans and Health Insurance Veterans and Health Insurance
Veterans and Health Insurance
Patrick Edlin
 
Mortality - HIV
Mortality - HIVMortality - HIV
Mortality - HIV
iPROVIBE
 
Aids/HIV
Aids/HIVAids/HIV
Aids/HIV
zonaira cheema
 
HIV AIDS IN CAMEOON
HIV AIDS IN CAMEOONHIV AIDS IN CAMEOON
HIV AIDS IN CAMEOON
Dr. Adidja AMANI, MD MPH
 
Module 10 hiv-aids legal & ethical issues
Module 10   hiv-aids legal & ethical issuesModule 10   hiv-aids legal & ethical issues
Module 10 hiv-aids legal & ethical issues
David Ngogoyo
 
Legal Advice Medical
Legal Advice MedicalLegal Advice Medical
Legal Advice Medical
legal1
 
Alerting the public HIV among African Americans
Alerting the public HIV among African AmericansAlerting the public HIV among African Americans
Alerting the public HIV among African Americans
Melinda Marshall, DrPH, RRT-NPS-TESOL
 

What's hot (14)

12.04.20 | COVID-19 Disparities in Black & Latino Communities: Implications f...
12.04.20 | COVID-19 Disparities in Black & Latino Communities: Implications f...12.04.20 | COVID-19 Disparities in Black & Latino Communities: Implications f...
12.04.20 | COVID-19 Disparities in Black & Latino Communities: Implications f...
 
Evaluating HIV Clinical Care Quality in Massachusetts Sites Supported through...
Evaluating HIV Clinical Care Quality in Massachusetts Sites Supported through...Evaluating HIV Clinical Care Quality in Massachusetts Sites Supported through...
Evaluating HIV Clinical Care Quality in Massachusetts Sites Supported through...
 
Illustrating HIV/AIDS in Southeast U.S.
Illustrating HIV/AIDS in Southeast U.S.Illustrating HIV/AIDS in Southeast U.S.
Illustrating HIV/AIDS in Southeast U.S.
 
Integrating HIV Prevention with Hepatitis C Co‐Infection Programs
Integrating HIV Prevention with Hepatitis C Co‐Infection ProgramsIntegrating HIV Prevention with Hepatitis C Co‐Infection Programs
Integrating HIV Prevention with Hepatitis C Co‐Infection Programs
 
San Diego Primary Care Providers' Attitudes to HIV and HIV Testing
San Diego Primary Care Providers' Attitudes to HIV and HIV TestingSan Diego Primary Care Providers' Attitudes to HIV and HIV Testing
San Diego Primary Care Providers' Attitudes to HIV and HIV Testing
 
Do 1 Thing - Dr. Stacey Trooskin
Do 1 Thing - Dr. Stacey TrooskinDo 1 Thing - Dr. Stacey Trooskin
Do 1 Thing - Dr. Stacey Trooskin
 
2017 Ottawa County Department of Public Health Annual Report
2017 Ottawa County Department of Public Health Annual Report2017 Ottawa County Department of Public Health Annual Report
2017 Ottawa County Department of Public Health Annual Report
 
Veterans and Health Insurance
Veterans and Health Insurance Veterans and Health Insurance
Veterans and Health Insurance
 
Mortality - HIV
Mortality - HIVMortality - HIV
Mortality - HIV
 
Aids/HIV
Aids/HIVAids/HIV
Aids/HIV
 
HIV AIDS IN CAMEOON
HIV AIDS IN CAMEOONHIV AIDS IN CAMEOON
HIV AIDS IN CAMEOON
 
Module 10 hiv-aids legal & ethical issues
Module 10   hiv-aids legal & ethical issuesModule 10   hiv-aids legal & ethical issues
Module 10 hiv-aids legal & ethical issues
 
Legal Advice Medical
Legal Advice MedicalLegal Advice Medical
Legal Advice Medical
 
Alerting the public HIV among African Americans
Alerting the public HIV among African AmericansAlerting the public HIV among African Americans
Alerting the public HIV among African Americans
 

Similar to HIV: NEW PUBLIC HEALTH INTERVENTIONS

CDC_HIV_JDaniels_writing sample
CDC_HIV_JDaniels_writing sampleCDC_HIV_JDaniels_writing sample
CDC_HIV_JDaniels_writing sample
Janina Daniels, MHSA
 
Annual Epidemiological Presentation, 2017 - Kathleen Brady, PDPH
Annual Epidemiological Presentation, 2017 - Kathleen Brady, PDPHAnnual Epidemiological Presentation, 2017 - Kathleen Brady, PDPH
Annual Epidemiological Presentation, 2017 - Kathleen Brady, PDPH
Office of HIV Planning
 
Global Medical Cures™ | HIV TESTING IN USA
Global Medical Cures™ | HIV TESTING IN USAGlobal Medical Cures™ | HIV TESTING IN USA
Global Medical Cures™ | HIV TESTING IN USA
Global Medical Cures™
 
Best Practices in STD Follow Up and Case Management
Best Practices in STD Follow Up and Case ManagementBest Practices in STD Follow Up and Case Management
Best Practices in STD Follow Up and Case Management
California School-Based Health Alliance
 
pozabilities_newsletter_vol3_web
pozabilities_newsletter_vol3_webpozabilities_newsletter_vol3_web
pozabilities_newsletter_vol3_web
Yvette Wasserman
 
OUR Time is NOW!
OUR Time is NOW!OUR Time is NOW!
OUR Time is NOW!
StandUp Tohivatl
 
Kathleen Brady Philadelphia HIV Epidemiologic Update 2015
Kathleen Brady Philadelphia HIV Epidemiologic Update 2015Kathleen Brady Philadelphia HIV Epidemiologic Update 2015
Kathleen Brady Philadelphia HIV Epidemiologic Update 2015
Office of HIV Planning
 
Dr. Kathleen Brady's 2013 Epidemiologic Update
Dr. Kathleen Brady's 2013 Epidemiologic UpdateDr. Kathleen Brady's 2013 Epidemiologic Update
Dr. Kathleen Brady's 2013 Epidemiologic Update
Office of HIV Planning
 
2014 Epidemiological Update by Dr. Kathleen Brady
2014 Epidemiological Update by Dr. Kathleen Brady2014 Epidemiological Update by Dr. Kathleen Brady
2014 Epidemiological Update by Dr. Kathleen Brady
Office of HIV Planning
 
Epidemiological Update 2017 (Positive Committee)
Epidemiological Update 2017 (Positive Committee)Epidemiological Update 2017 (Positive Committee)
Epidemiological Update 2017 (Positive Committee)
Office of HIV Planning
 
Early Identification of Individuals with HIV/AIDS
Early Identification of Individuals with HIV/AIDSEarly Identification of Individuals with HIV/AIDS
Early Identification of Individuals with HIV/AIDS
Office of HIV Planning
 
Read the article on the following 2 pages, Fighting HIV a Commu.docx
Read the article on the following 2 pages, Fighting HIV a Commu.docxRead the article on the following 2 pages, Fighting HIV a Commu.docx
Read the article on the following 2 pages, Fighting HIV a Commu.docx
catheryncouper
 
AIDS Legal & Ethical Implications HIV.pptx
AIDS Legal & Ethical Implications HIV.pptxAIDS Legal & Ethical Implications HIV.pptx
AIDS Legal & Ethical Implications HIV.pptx
aiabkkau
 
The HIV Engagement in Care Cascade by Dr. Kathleen Brady
The HIV Engagement in Care Cascade by Dr. Kathleen BradyThe HIV Engagement in Care Cascade by Dr. Kathleen Brady
The HIV Engagement in Care Cascade by Dr. Kathleen Brady
Office of HIV Planning
 
HIV 101 Wihan
HIV 101 WihanHIV 101 Wihan
HIV 101 Wihan
sheyonnm
 
Hiv and aids: legal & ethical implications
Hiv and aids: legal & ethical implicationsHiv and aids: legal & ethical implications
Hiv and aids: legal & ethical implications
Dr Sandeep Kumar Giri
 
Barriers of HIV Prevention through Treatment
Barriers of HIV Prevention through TreatmentBarriers of HIV Prevention through Treatment
Barriers of HIV Prevention through Treatment
UC San Diego AntiViral Research Center
 
2016HIV_STI_SurveillanceReport
2016HIV_STI_SurveillanceReport2016HIV_STI_SurveillanceReport
2016HIV_STI_SurveillanceReport
Karen L. Canada M.A.
 
Chris Beyrer: "State of the Science: Key populations"
Chris Beyrer: "State of the Science: Key populations"Chris Beyrer: "State of the Science: Key populations"
Chris Beyrer: "State of the Science: Key populations"
HopkinsCFAR
 
Webinar on Integrating HIV Education
Webinar on Integrating HIV EducationWebinar on Integrating HIV Education
Webinar on Integrating HIV Education
CHC Connecticut
 

Similar to HIV: NEW PUBLIC HEALTH INTERVENTIONS (20)

CDC_HIV_JDaniels_writing sample
CDC_HIV_JDaniels_writing sampleCDC_HIV_JDaniels_writing sample
CDC_HIV_JDaniels_writing sample
 
Annual Epidemiological Presentation, 2017 - Kathleen Brady, PDPH
Annual Epidemiological Presentation, 2017 - Kathleen Brady, PDPHAnnual Epidemiological Presentation, 2017 - Kathleen Brady, PDPH
Annual Epidemiological Presentation, 2017 - Kathleen Brady, PDPH
 
Global Medical Cures™ | HIV TESTING IN USA
Global Medical Cures™ | HIV TESTING IN USAGlobal Medical Cures™ | HIV TESTING IN USA
Global Medical Cures™ | HIV TESTING IN USA
 
Best Practices in STD Follow Up and Case Management
Best Practices in STD Follow Up and Case ManagementBest Practices in STD Follow Up and Case Management
Best Practices in STD Follow Up and Case Management
 
pozabilities_newsletter_vol3_web
pozabilities_newsletter_vol3_webpozabilities_newsletter_vol3_web
pozabilities_newsletter_vol3_web
 
OUR Time is NOW!
OUR Time is NOW!OUR Time is NOW!
OUR Time is NOW!
 
Kathleen Brady Philadelphia HIV Epidemiologic Update 2015
Kathleen Brady Philadelphia HIV Epidemiologic Update 2015Kathleen Brady Philadelphia HIV Epidemiologic Update 2015
Kathleen Brady Philadelphia HIV Epidemiologic Update 2015
 
Dr. Kathleen Brady's 2013 Epidemiologic Update
Dr. Kathleen Brady's 2013 Epidemiologic UpdateDr. Kathleen Brady's 2013 Epidemiologic Update
Dr. Kathleen Brady's 2013 Epidemiologic Update
 
2014 Epidemiological Update by Dr. Kathleen Brady
2014 Epidemiological Update by Dr. Kathleen Brady2014 Epidemiological Update by Dr. Kathleen Brady
2014 Epidemiological Update by Dr. Kathleen Brady
 
Epidemiological Update 2017 (Positive Committee)
Epidemiological Update 2017 (Positive Committee)Epidemiological Update 2017 (Positive Committee)
Epidemiological Update 2017 (Positive Committee)
 
Early Identification of Individuals with HIV/AIDS
Early Identification of Individuals with HIV/AIDSEarly Identification of Individuals with HIV/AIDS
Early Identification of Individuals with HIV/AIDS
 
Read the article on the following 2 pages, Fighting HIV a Commu.docx
Read the article on the following 2 pages, Fighting HIV a Commu.docxRead the article on the following 2 pages, Fighting HIV a Commu.docx
Read the article on the following 2 pages, Fighting HIV a Commu.docx
 
AIDS Legal & Ethical Implications HIV.pptx
AIDS Legal & Ethical Implications HIV.pptxAIDS Legal & Ethical Implications HIV.pptx
AIDS Legal & Ethical Implications HIV.pptx
 
The HIV Engagement in Care Cascade by Dr. Kathleen Brady
The HIV Engagement in Care Cascade by Dr. Kathleen BradyThe HIV Engagement in Care Cascade by Dr. Kathleen Brady
The HIV Engagement in Care Cascade by Dr. Kathleen Brady
 
HIV 101 Wihan
HIV 101 WihanHIV 101 Wihan
HIV 101 Wihan
 
Hiv and aids: legal & ethical implications
Hiv and aids: legal & ethical implicationsHiv and aids: legal & ethical implications
Hiv and aids: legal & ethical implications
 
Barriers of HIV Prevention through Treatment
Barriers of HIV Prevention through TreatmentBarriers of HIV Prevention through Treatment
Barriers of HIV Prevention through Treatment
 
2016HIV_STI_SurveillanceReport
2016HIV_STI_SurveillanceReport2016HIV_STI_SurveillanceReport
2016HIV_STI_SurveillanceReport
 
Chris Beyrer: "State of the Science: Key populations"
Chris Beyrer: "State of the Science: Key populations"Chris Beyrer: "State of the Science: Key populations"
Chris Beyrer: "State of the Science: Key populations"
 
Webinar on Integrating HIV Education
Webinar on Integrating HIV EducationWebinar on Integrating HIV Education
Webinar on Integrating HIV Education
 

More from UC San Diego AntiViral Research Center

10.20.23 | Frailty in People Aging with HIV
10.20.23 | Frailty in People Aging with HIV10.20.23 | Frailty in People Aging with HIV
10.20.23 | Frailty in People Aging with HIV
UC San Diego AntiViral Research Center
 
06.11.21 | Practical Aspects of Dealing with Weight Gain in People with HIV
06.11.21 | Practical Aspects of Dealing with Weight Gain in People with HIV06.11.21 | Practical Aspects of Dealing with Weight Gain in People with HIV
06.11.21 | Practical Aspects of Dealing with Weight Gain in People with HIV
UC San Diego AntiViral Research Center
 
05.07.21 | Not the Same Old Blues: Trails of the Efforts to Improve PrEP Upta...
05.07.21 | Not the Same Old Blues: Trails of the Efforts to Improve PrEP Upta...05.07.21 | Not the Same Old Blues: Trails of the Efforts to Improve PrEP Upta...
05.07.21 | Not the Same Old Blues: Trails of the Efforts to Improve PrEP Upta...
UC San Diego AntiViral Research Center
 
04.16.21 | Entering a New Era of HIV Care: Long-Acting Injectables for HIV
04.16.21 | Entering a New Era of HIV Care: Long-Acting Injectables for HIV04.16.21 | Entering a New Era of HIV Care: Long-Acting Injectables for HIV
04.16.21 | Entering a New Era of HIV Care: Long-Acting Injectables for HIV
UC San Diego AntiViral Research Center
 
04.09.21 | Making Sense of the COVID-19 Data in Persons with HIV
04.09.21 | Making Sense of the COVID-19 Data in Persons with HIV04.09.21 | Making Sense of the COVID-19 Data in Persons with HIV
04.09.21 | Making Sense of the COVID-19 Data in Persons with HIV
UC San Diego AntiViral Research Center
 
03.19.21 | Updates in HIV Prevention from Virtual CROI 2021
03.19.21 | Updates in HIV Prevention from Virtual CROI 202103.19.21 | Updates in HIV Prevention from Virtual CROI 2021
03.19.21 | Updates in HIV Prevention from Virtual CROI 2021
UC San Diego AntiViral Research Center
 
03.05.21 | Creating an Emergency Response System for Emerging Infectious Dise...
03.05.21 | Creating an Emergency Response System for Emerging Infectious Dise...03.05.21 | Creating an Emergency Response System for Emerging Infectious Dise...
03.05.21 | Creating an Emergency Response System for Emerging Infectious Dise...
UC San Diego AntiViral Research Center
 
02.05.21 | COVID-19 and Pregnancy
02.05.21 | COVID-19 and Pregnancy02.05.21 | COVID-19 and Pregnancy
02.05.21 | COVID-19 and Pregnancy
UC San Diego AntiViral Research Center
 
01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings
01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings
01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings
UC San Diego AntiViral Research Center
 
01.22.21 | Video DOT for Monitoring Treatment Adherence for TB, LTBI and Beyond
01.22.21 | Video DOT for Monitoring Treatment Adherence for TB, LTBI and Beyond01.22.21 | Video DOT for Monitoring Treatment Adherence for TB, LTBI and Beyond
01.22.21 | Video DOT for Monitoring Treatment Adherence for TB, LTBI and Beyond
UC San Diego AntiViral Research Center
 
Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)
Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)
Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)
UC San Diego AntiViral Research Center
 
Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)
Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)
Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)
UC San Diego AntiViral Research Center
 
Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)
Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)
Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)
UC San Diego AntiViral Research Center
 
11.13.20 | The Impact of COVID-19 on the Opioid Epidemic
11.13.20 | The Impact of COVID-19 on the Opioid Epidemic11.13.20 | The Impact of COVID-19 on the Opioid Epidemic
11.13.20 | The Impact of COVID-19 on the Opioid Epidemic
UC San Diego AntiViral Research Center
 
10.23.20 | Rise Above COVID (Treatments for COVID-19)
10.23.20 | Rise Above COVID (Treatments for COVID-19)10.23.20 | Rise Above COVID (Treatments for COVID-19)
10.23.20 | Rise Above COVID (Treatments for COVID-19)
UC San Diego AntiViral Research Center
 
10.16.20 | TB or not TB (Burmese Refugee with Brain Mass)
10.16.20 | TB or not TB (Burmese Refugee with Brain Mass)10.16.20 | TB or not TB (Burmese Refugee with Brain Mass)
10.16.20 | TB or not TB (Burmese Refugee with Brain Mass)
UC San Diego AntiViral Research Center
 
09.18.20 | Sustaining the HIV Workforce through Med Ed Innovations
09.18.20 | Sustaining the HIV Workforce through Med Ed Innovations09.18.20 | Sustaining the HIV Workforce through Med Ed Innovations
09.18.20 | Sustaining the HIV Workforce through Med Ed Innovations
UC San Diego AntiViral Research Center
 
09.11.20 | Review of New Antiretrovirals
09.11.20 | Review of New Antiretrovirals09.11.20 | Review of New Antiretrovirals
09.11.20 | Review of New Antiretrovirals
UC San Diego AntiViral Research Center
 
08.28.20 | Update on the Epidemiology of HCV Infection and National Screening...
08.28.20 | Update on the Epidemiology of HCV Infection and National Screening...08.28.20 | Update on the Epidemiology of HCV Infection and National Screening...
08.28.20 | Update on the Epidemiology of HCV Infection and National Screening...
UC San Diego AntiViral Research Center
 
08.21.20 | Sexually Transmitted Infections – 2020 Update
08.21.20 | Sexually Transmitted Infections – 2020 Update08.21.20 | Sexually Transmitted Infections – 2020 Update
08.21.20 | Sexually Transmitted Infections – 2020 Update
UC San Diego AntiViral Research Center
 

More from UC San Diego AntiViral Research Center (20)

10.20.23 | Frailty in People Aging with HIV
10.20.23 | Frailty in People Aging with HIV10.20.23 | Frailty in People Aging with HIV
10.20.23 | Frailty in People Aging with HIV
 
06.11.21 | Practical Aspects of Dealing with Weight Gain in People with HIV
06.11.21 | Practical Aspects of Dealing with Weight Gain in People with HIV06.11.21 | Practical Aspects of Dealing with Weight Gain in People with HIV
06.11.21 | Practical Aspects of Dealing with Weight Gain in People with HIV
 
05.07.21 | Not the Same Old Blues: Trails of the Efforts to Improve PrEP Upta...
05.07.21 | Not the Same Old Blues: Trails of the Efforts to Improve PrEP Upta...05.07.21 | Not the Same Old Blues: Trails of the Efforts to Improve PrEP Upta...
05.07.21 | Not the Same Old Blues: Trails of the Efforts to Improve PrEP Upta...
 
04.16.21 | Entering a New Era of HIV Care: Long-Acting Injectables for HIV
04.16.21 | Entering a New Era of HIV Care: Long-Acting Injectables for HIV04.16.21 | Entering a New Era of HIV Care: Long-Acting Injectables for HIV
04.16.21 | Entering a New Era of HIV Care: Long-Acting Injectables for HIV
 
04.09.21 | Making Sense of the COVID-19 Data in Persons with HIV
04.09.21 | Making Sense of the COVID-19 Data in Persons with HIV04.09.21 | Making Sense of the COVID-19 Data in Persons with HIV
04.09.21 | Making Sense of the COVID-19 Data in Persons with HIV
 
03.19.21 | Updates in HIV Prevention from Virtual CROI 2021
03.19.21 | Updates in HIV Prevention from Virtual CROI 202103.19.21 | Updates in HIV Prevention from Virtual CROI 2021
03.19.21 | Updates in HIV Prevention from Virtual CROI 2021
 
03.05.21 | Creating an Emergency Response System for Emerging Infectious Dise...
03.05.21 | Creating an Emergency Response System for Emerging Infectious Dise...03.05.21 | Creating an Emergency Response System for Emerging Infectious Dise...
03.05.21 | Creating an Emergency Response System for Emerging Infectious Dise...
 
02.05.21 | COVID-19 and Pregnancy
02.05.21 | COVID-19 and Pregnancy02.05.21 | COVID-19 and Pregnancy
02.05.21 | COVID-19 and Pregnancy
 
01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings
01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings
01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings
 
01.22.21 | Video DOT for Monitoring Treatment Adherence for TB, LTBI and Beyond
01.22.21 | Video DOT for Monitoring Treatment Adherence for TB, LTBI and Beyond01.22.21 | Video DOT for Monitoring Treatment Adherence for TB, LTBI and Beyond
01.22.21 | Video DOT for Monitoring Treatment Adherence for TB, LTBI and Beyond
 
Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)
Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)
Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)
 
Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)
Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)
Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)
 
Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)
Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)
Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)
 
11.13.20 | The Impact of COVID-19 on the Opioid Epidemic
11.13.20 | The Impact of COVID-19 on the Opioid Epidemic11.13.20 | The Impact of COVID-19 on the Opioid Epidemic
11.13.20 | The Impact of COVID-19 on the Opioid Epidemic
 
10.23.20 | Rise Above COVID (Treatments for COVID-19)
10.23.20 | Rise Above COVID (Treatments for COVID-19)10.23.20 | Rise Above COVID (Treatments for COVID-19)
10.23.20 | Rise Above COVID (Treatments for COVID-19)
 
10.16.20 | TB or not TB (Burmese Refugee with Brain Mass)
10.16.20 | TB or not TB (Burmese Refugee with Brain Mass)10.16.20 | TB or not TB (Burmese Refugee with Brain Mass)
10.16.20 | TB or not TB (Burmese Refugee with Brain Mass)
 
09.18.20 | Sustaining the HIV Workforce through Med Ed Innovations
09.18.20 | Sustaining the HIV Workforce through Med Ed Innovations09.18.20 | Sustaining the HIV Workforce through Med Ed Innovations
09.18.20 | Sustaining the HIV Workforce through Med Ed Innovations
 
09.11.20 | Review of New Antiretrovirals
09.11.20 | Review of New Antiretrovirals09.11.20 | Review of New Antiretrovirals
09.11.20 | Review of New Antiretrovirals
 
08.28.20 | Update on the Epidemiology of HCV Infection and National Screening...
08.28.20 | Update on the Epidemiology of HCV Infection and National Screening...08.28.20 | Update on the Epidemiology of HCV Infection and National Screening...
08.28.20 | Update on the Epidemiology of HCV Infection and National Screening...
 
08.21.20 | Sexually Transmitted Infections – 2020 Update
08.21.20 | Sexually Transmitted Infections – 2020 Update08.21.20 | Sexually Transmitted Infections – 2020 Update
08.21.20 | Sexually Transmitted Infections – 2020 Update
 

Recently uploaded

Recent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptxRecent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptx
DrGirishJHoogar
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
Dr.pavithra Anandan
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
LEFLOT Jean-Louis
 
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan PatroJune 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
Kanhu Charan
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdfNAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
Rahul Sen
 
Breast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapyBreast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapy
Dr. Sumit KUMAR
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.
Gokuldas Hospital
 
Know the difference between Endodontics and Orthodontics.
Know the difference between Endodontics and Orthodontics.Know the difference between Endodontics and Orthodontics.
Know the difference between Endodontics and Orthodontics.
Gokuldas Hospital
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
Dr. Nikhilkumar Sakle
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
FFragrant
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
Ageing, the Elderly, Gerontology and Public Health
Ageing, the Elderly, Gerontology and Public HealthAgeing, the Elderly, Gerontology and Public Health
Ageing, the Elderly, Gerontology and Public Health
phuakl
 
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdfOphthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
MuhammadMuneer49
 
Pollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdfPollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdf
Chulalongkorn Allergy and Clinical Immunology Research Group
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
NX Healthcare
 
Skin Diseases That Happen During Summer.
 Skin Diseases That Happen During Summer. Skin Diseases That Happen During Summer.
Skin Diseases That Happen During Summer.
Gokuldas Hospital
 

Recently uploaded (20)

Recent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptxRecent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptx
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
 
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan PatroJune 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdfNAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
 
Breast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapyBreast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapy
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.
 
Know the difference between Endodontics and Orthodontics.
Know the difference between Endodontics and Orthodontics.Know the difference between Endodontics and Orthodontics.
Know the difference between Endodontics and Orthodontics.
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
Ageing, the Elderly, Gerontology and Public Health
Ageing, the Elderly, Gerontology and Public HealthAgeing, the Elderly, Gerontology and Public Health
Ageing, the Elderly, Gerontology and Public Health
 
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdfOphthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
 
Pollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdfPollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdf
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
 
Skin Diseases That Happen During Summer.
 Skin Diseases That Happen During Summer. Skin Diseases That Happen During Summer.
Skin Diseases That Happen During Summer.
 

HIV: NEW PUBLIC HEALTH INTERVENTIONS

  • 1.
  • 2. HIV: NEW PUBLIC HEALTH INTERVENTIONS Patrick Loose & Heidi Aiem HIV, STD & Hepatitis Branch Public Health Services County of San Diego Health & Human Services Agency
  • 4. NATIONAL HIV/AIDS STRATEGY The United States will become a place where new HIV infections are rare and when they do occur, every person regardless of age, gender, race/ethnicity, sexual orientation, gender identity or socio-economic circumstance, will have unfettered access to high quality, life- extending care, free from stigma and discrimination.
  • 5. HIV IN SAN DIEGO COUNTY Demographic Group 2014- PREVALENCE AS OF 12/31/14 Race/Ethnicity HIV AIDS # % # % White, not Hispanic 6,623 52.1 3,727 49.6 Black, not Hispanic 1,793 14.1 1,142 15.2 Hispanic 3,674 28.9 2,330 31.0 Asian/Pacific Islander 420 3.3 218 2.9 American Indian/Alaska Native 89 0.7 38 0.5 Multi-Race 114 0.9 60 0.8 Total 12,713 100 7,515 100
  • 8. CASCADE OF CARE 100% 43% 51% 100% 57% 67% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Total living with HIVa Retention in careb Viral suppressionc Percent Persons living with HIV, diagnosed as a resident or known to have moved to San Diego (N=16,898) Persons living with HIV, recently diagnosed or recently in care in San Diego (N=12,863) Total living with HIVa Virally suppressedcHad > 2 lab testsb aPersons living with HIV, diagnosed as a resident of San Diego or known to have moved to San Diego defined as persons diagnosed with HIV through 12/31/2013 and living through 12/31/2014, regardless of stage of disease. Recently diagnosed or recently in care in San Diego defined as persons diagnosed with HIV 2009-2013 or diagnosed prior to 2009 and having at least one CD4 or viral load between 2010 and 2014, living through 12/31/2014, regardless of stage of disease. bOf the total, persons who had >2 CD4 or viral load tests at least 3 months apart during 2014. cOf the total, persons wih virologic supression (<200 copies/mL) at most recent test during 2014. HIV Care Continuum, San Diego County, 2014
  • 9. 36% 43%43% 49% 45% 46% 38% 44% 34% 28%27%* 28%* 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 1 2 Percent MSM Continuum of HIV Care by Race/ethnicity San Diego County, FY 2012/2013 Overall Asian/PI Hispanic White American Indian Black *Statistically lower than the overall percent; p<.05. aSan Diego data source: FY 12/13 unmet need file. Of those diagnosed with HIV disease, persons who had >=2 CD4 or viral load tests at least 3 months apart during FY 12/13. bSan Diego data source: Of those diagnosed with HIV disease, persons with virologic suppression (<=200 copies/mL) at most recent test during FY 12/13. Viral suppressionbRetention in carea CONTINUUM OF CARE BY RACE/ETHNICITY
  • 11.
  • 13. THREE FUNDAMENTAL STRATEGIES Prevent new infections Identify & link everyone with HIV to Treatment Retain everyone living with HIV in care
  • 14. LEG AUTHORITY LHO AUTHORITY TO USE HIV SURVEILLANCE DATA FOR PARTNER SERVICES  California Health and Safety Code (HSC) Section 120175 provides LHOs with broad authority to proactively investigate cases of disease, to ascertain the infection source, and take measures as may be necessary to prevent the spread of the disease or occurrence of additional cases. Thus, LHOs or their designees, who may be STD Control Branch staff or DIS/partner services staff working on the LHO’s behalf, may use HIV surveillance data to identify HIV-infected individuals and initiate partner services with them. HIV surveillance data consists of LHD-acquired/developed data or data shared with the LHO by the state or another jurisdictional LHO. LHOs and their DIS/partner services staff should ensure that their activities adhere to CDC security and confidentiality requirements and California HSC confidentiality protections within both the surveillance and partner services areas before proceeding with utilizing HIV surveillance data to identify potential clients for partner services.
  • 15. LOCAL HEALTH OFFICERS OR THEIR DESIGNEES, INCLUDING PARTNER SERVICES STAFF, MAY:  Tell anyone reasonably believed to be a spouse, or sex, or needle-sharing partner of a person who has tested positive for HIV about their exposure to HIV. The LHO or their designees may not disclose any identifying information about the person with HIV or the physician making the report to the LHD. Any person to whom the disclosure is made must be referred for appropriate care and follow-up. Health and Safety Code (HSC) Section 121015[d)])
  • 16. STATE/LOCAL HEALTH DEPARTMENT HIV SURVEILLANCE STAFF MAY:  Disclose personally identifying information about HIV-positive reported individuals to other local and state health department staff without written authorization. HSC Section 121025(b) specifically authorizes state and local public health agencies to disclose personally identifying information to CDPH and to other local public health agencies when the information is necessary for the investigation, control, or surveillance of disease. This includes partner services. (HSC Section 121015[d)])
  • 17. PHYSICIANS OR SURGEONS MAY:  With the written consent of the patient with HIV, provide LHO or the LHD partner services staff the patient’s contact information for partner services. (HSC Section 121015[a)])  Without the written consent of the patient with HIV, notify the spouse, or sex, or needle-sharing partners of the patient if the physician or surgeon: 1) discusses the test results with the patient; 2) offers the patient appropriate educational and psychological counseling, including information on the risks of transmitting HIV to other people and methods of avoiding those risks; 3) attempts to obtain the patient’s voluntary consent for notification of their contacts; and 4) notifies the patient of their intent to notify the patient’s contacts prior to any notification. (HSC Section 121015[b)])
  • 18. HIV & STD REPORTING STD REPORTING  STD Surveillance Unit  619-692-8501 HIV REPORTING  HIV/AIDS Epidemiology Unit  619-692-8545
  • 23.
  • 24.  Patrick Loose, Chief, Patrick.Loose@sdcounty.ca.gov  Heidi Aiem, Clinic Services Coordination, Heidi.Aiem@sdcounty.ca.gov  www.stdsandiego.org  HIV, STD & Hepatitis Branch: http://www.sandiegocounty.gov/hhsa/programs/phs/hiv_std_hepatitis_branch/inde x.html  HIV/AIDS Epidemiology Unit: http://www.sandiegocounty.gov/hhsa/programs/phs/hiv_aids_epidemiology_unit/re ports_and_statistics.html